Researchers at NYU Pain Research Center have identified a receptor, EP2, responsible for pain but not inflammation. Targeting EP2 in Schwann cells allowed mice to experience complete pain relief without affecting healing. This breakthrough could pave the way for safer painkillers, especially for chronic conditions like arthritis and migraines, avoiding harmful side effects of traditional NSAIDs.